Mingdu Zhiyun key facts
as of Oct 2026- Developer of full life-cycle management technology designed for pharmaceutical companies.
- Mingdu Zhiyun is valued at approximately $341.5M as of Oct 2026 (last reported valuation).
- It has raised $33.6M; the latest was Later Stage VC in Jan 2026.
- Notable investors include Shenzhen Capital Group, Zheshang Venture Capital, China Merchants Venture Capital, Hangzhou Hi-Tech Financial Investment Group, CASH Capital — 13 tracked in total.
- Status: Privately Held (backing).
Mingdu Zhiyun's last reported valuation, May 2021. Nothing priced has surfaced since.
- ·The complete investor list: 13 names
- ·Watch Mingdu Zhiyun: the Monday email on marks, rounds and moves
Mingdu Zhiyun funding rounds
No funding rounds for Mingdu Zhiyun are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Mingdu Zhiyun
13+Membership and data by Private Market View
Mingdu Zhiyun valuation
Mingdu Zhiyun's last reported valuation was $342 million in May 2021. No priced round, secondary trade or fund mark has surfaced since.
Mingdu Zhiyun investors
13 investors are on record for Mingdu Zhiyun, including Shenzhen Capital Group, Zheshang Venture Capital, China Merchants Venture Capital and Hangzhou Hi-Tech Financial Investment Group.
About Mingdu Zhiyun
Developer of full life-cycle management technology designed for pharmaceutical companies. The company aims to provide solutions covering research and development, production, warehousing, and logistics, which offer pharmaceutical companies full life cycle solutions from R&D to production, enabling drug makers to simplify and increase the efficiency of the application, production, and registration of pharmaceutical products.
- Sector
- Information Technology
- HQ
- Hangzhou, China
- Founded
- 2017
- Employees
- 500
- Website
- mingdutech.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.